Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

August 01, 2006; Volume 34,Issue 8

Short Communications

  • You have access
    INHIBITION OF UDP-GLUCURONOSYLTRANSFERASE 2B7-CATALYZED MORPHINE GLUCURONIDATION BY KETOCONAZOLE: DUAL MECHANISMS INVOLVING A NOVEL NONCOMPETITIVE MODE
    Shuso Takeda, Yurie Kitajima, Yuji Ishii, Yoshio Nishimura, Peter I. Mackenzie, Kazuta Oguri and Hideyuki Yamada
    Drug Metabolism and Disposition August 2006, 34 (8) 1277-1282; DOI: https://doi.org/10.1124/dmd.106.009738
  • You have access
    NMR CHARACTERIZATION OF AN S-LINKED GLUCURONIDE METABOLITE OF THE POTENT, NOVEL, NONSTEROIDAL PROGESTERONE AGONIST TANAPROGET
    Kelly A. Keating, Oliver McConnell, Yingru Zhang, Li Shen, William Demaio, Larry Mallis, Sayed Elmarakby and Appavu Chandrasekaran
    Drug Metabolism and Disposition August 2006, 34 (8) 1283-1287; DOI: https://doi.org/10.1124/dmd.105.008763
  • You have access
    KINETIC ISOTOPE EFFECTS IMPLICATE A SINGLE OXIDANT FOR CYTOCHROME P450-MEDIATED O-DEALKYLATION, N-OXYGENATION, AND AROMATIC HYDROXYLATION OF 6-METHOXYQUINOLINE
    Tamara S. Dowers and Jeffrey P. Jones
    Drug Metabolism and Disposition August 2006, 34 (8) 1288-1290; DOI: https://doi.org/10.1124/dmd.106.010280

Articles

  • You have access
    EVALUATION OF TIME-DEPENDENT CYTOCHROME P450 INHIBITION USING CULTURED HUMAN HEPATOCYTES
    Dermot F. McGinnity, Amanda J. Berry, Jane R. Kenny, Ken Grime and Robert J. Riley
    Drug Metabolism and Disposition August 2006, 34 (8) 1291-1300; DOI: https://doi.org/10.1124/dmd.106.009969
  • You have access
    HEPATIC AND EXTRAHEPATIC SYNTHESIS AND DISPOSITION OF DINITROPHENYL-S-GLUTATHIONE IN BILE DUCT-LIGATED RATS
    Silvina S. M. Villanueva, María L. Ruiz, Carol J. Soroka, Shi-Ying Cai, Marcelo G. Luquita, Adriana M. Torres, Enrique J. Sánchez Pozzi, José M. Pellegrino, James L. Boyer, Viviana A. Catania and Aldo D. Mottino
    Drug Metabolism and Disposition August 2006, 34 (8) 1301-1309; DOI: https://doi.org/10.1124/dmd.106.009415
  • You have access
    METABOLISM OF NOMIFENSINE TO A DIHYDROISOQUINOLINIUM ION METABOLITE BY HUMAN MYELOPEROXIDASE, HEMOGLOBIN, MONOAMINE OXIDASE A, AND CYTOCHROME P450 ENZYMES
    R. Scott Obach and Deepak K. Dalvie
    Drug Metabolism and Disposition August 2006, 34 (8) 1310-1316; DOI: https://doi.org/10.1124/dmd.106.010173
  • You have access
    SELECTIVE METABOLISM OF VINCRISTINE IN VITRO BY CYP3A5
    Jennifer B. Dennison, Palaniappan Kulanthaivel, Robert J. Barbuch, Jamie L. Renbarger, William J. Ehlhardt and Stephen D. Hall
    Drug Metabolism and Disposition August 2006, 34 (8) 1317-1327; DOI: https://doi.org/10.1124/dmd.106.009902
  • You have access
    QUANTITATIVE DETERMINATION OF METABOLIC PRODUCTS OF 19-NORANDROSTENEDIOL IN HUMAN PLASMA USING GAS CHROMATOGRAPHY/MASS SPECTROMETRY
    Yvonne Schrader, Mario Thevis and Wilhelm Schänzer
    Drug Metabolism and Disposition August 2006, 34 (8) 1328-1335; DOI: https://doi.org/10.1124/dmd.106.010165
  • You have access
    IN VITRO AND IN VIVO CORRELATION OF HEPATIC TRANSPORTER EFFECTS ON ERYTHROMYCIN METABOLISM: CHARACTERIZING THE IMPORTANCE OF TRANSPORTER-ENZYME INTERPLAY
    Justine L. Lam, Hideaki Okochi, Yong Huang and Leslie Z. Benet
    Drug Metabolism and Disposition August 2006, 34 (8) 1336-1344; DOI: https://doi.org/10.1124/dmd.106.009258
  • You have access
    PHARMACOKINETICS AND METABOLISM OF THE FLAVONOID SCUTELLARIN IN HUMANS AFTER A SINGLE ORAL ADMINISTRATION
    Xiaoyan Chen, Liang Cui, Xiaotao Duan, Bin Ma and Dafang Zhong
    Drug Metabolism and Disposition August 2006, 34 (8) 1345-1352; DOI: https://doi.org/10.1124/dmd.106.009779
  • You have access
    DIFFERENTIAL EFFECTS OF THE OXIDIZED METABOLITES OF OLTIPRAZ ON THE ACTIVATION OF CCAAT/ENHANCER BINDING PROTEIN-β AND NF-E2-RELATED FACTOR-2 FOR GSTA2 GENE INDUCTION
    Myong Suk Ko, Seung Jin Lee, Jin Wan Kim, Jee Woong Lim and Sang Geon Kim
    Drug Metabolism and Disposition August 2006, 34 (8) 1353-1360; DOI: https://doi.org/10.1124/dmd.106.009514
  • You have access
    EFFECT OF CYTOCHROMES P450 CHEMICAL INHIBITORS AND MONOCLONAL ANTIBODIES ON HUMAN LIVER MICROSOMAL ESTERASE ACTIVITY
    Stacey L. Polsky-Fisher, Hong Cao, Ping Lu and Christopher R. Gibson
    Drug Metabolism and Disposition August 2006, 34 (8) 1361-1366; DOI: https://doi.org/10.1124/dmd.106.009704
  • You have access
    SPECIES DIFFERENCES IN METABOLISM AND PHARMACOKINETICS OF A SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST IN RATS AND DOGS: FORMATION OF A UNIQUE GLUTATHIONE ADDUCT IN THE RAT
    M. Reza Anari, Mellissa D. Creighton, Jason S. Ngui, Richard A. Tschirret-Guth, Yohannes Teffera, George A. Doss, Wei Tang, Nathan X. Yu, Suzanne L. Ciccotto, Donald F. Hobra, John B. Coleman, Stella H. Vincent and David C. Evans
    Drug Metabolism and Disposition August 2006, 34 (8) 1367-1375; DOI: https://doi.org/10.1124/dmd.105.009027
  • You have access
    INDUCTION OF CYP1A AND CYP2-MEDIATED ARACHIDONIC ACID EPOXYGENATION AND SUPPRESSION OF 20-HYDROXYEICOSATETRAENOIC ACID BY IMIDAZOLE DERIVATIVES INCLUDING THE AROMATASE INHIBITOR VOROZOLE
    Silvia Diani-Moore, Fotini Papachristou, Erin Labitzke and Arleen B. Rifkind
    Drug Metabolism and Disposition August 2006, 34 (8) 1376-1385; DOI: https://doi.org/10.1124/dmd.106.009498
  • You have access
    IN SILICO PREDICTION OF DRUG BINDING TO CYP2D6: IDENTIFICATION OF A NEW METABOLITE OF METOCLOPRAMIDE
    Jinglei Yu, Mark J. I. Paine, Jean-Didier Maréchal, Carol A. Kemp, Clive J. Ward, Simon Brown, Michael J. Sutcliffe, Gordon C. K. Roberts, Elaine M. Rankin and C. Roland Wolf
    Drug Metabolism and Disposition August 2006, 34 (8) 1386-1392; DOI: https://doi.org/10.1124/dmd.106.009852
  • You have access
    INTRAVENOUSLY ADMINISTERED SHORT INTERFERING RNA ACCUMULATES IN THE KIDNEY AND SELECTIVELY SUPPRESSES GENE FUNCTION IN RENAL PROXIMAL TUBULES
    Femke M. van de Water, Otto C. Boerman, Alfons C. Wouterse, Janny G. P. Peters, Frans G. M. Russel and Rosalinde Masereeuw
    Drug Metabolism and Disposition August 2006, 34 (8) 1393-1397; DOI: https://doi.org/10.1124/dmd.106.009555
  • You have access
    THE ENVIRONMENTAL POLLUTANT AND CARCINOGEN 3-NITROBENZANTHRONE AND ITS HUMAN METABOLITE 3-AMINOBENZANTHRONE ARE POTENT INDUCERS OF RAT HEPATIC CYTOCHROMES P450 1A1 AND -1A2 AND NAD(P)H:QUINONE OXIDOREDUCTASE
    Marie Stiborová, Helena Dračínská, Jana Hájková, Pavla Kadeřábková, Eva Frei, Heinz H. Schmeiser, Pavel Souček, David H. Phillips and Volker M. Arlt
    Drug Metabolism and Disposition August 2006, 34 (8) 1398-1405; DOI: https://doi.org/10.1124/dmd.106.009373
  • You have access
    N-GLUCURONIDATION OF PERFLUOROOCTANESULFONAMIDE BY HUMAN, RAT, DOG, AND MONKEY LIVER MICROSOMES AND BY EXPRESSED RAT AND HUMAN UDP-GLUCURONOSYLTRANSFERASES
    Lin Xu, Daria M. Krenitsky, Andrew M. Seacat, John L. Butenhoff, Thomas R. Tephly and M. W. Anders
    Drug Metabolism and Disposition August 2006, 34 (8) 1406-1410; DOI: https://doi.org/10.1124/dmd.106.009399
  • You have access
    NEW CYTOCHROME P450 2D6*56 ALLELE IDENTIFIED BY GENOTYPE/PHENOTYPE ANALYSIS OF CRYOPRESERVED HUMAN HEPATOCYTES
    Li Li, Run-Mei Pan, Todd D. Porter, Neil S. Jensen, Paul Silber, Guy Russo, John A. Tine, John Heim, Barbara Ring and Peter J. Wedlund
    Drug Metabolism and Disposition August 2006, 34 (8) 1411-1416; DOI: https://doi.org/10.1124/dmd.106.009548
  • You have access
    COVALENT BINDING OF RADIOACTIVITY FROM [14C]ROFECOXIB, BUT NOT [14C]CELECOXIB OR [14C]CS-706, TO THE ARTERIAL ELASTIN OF RATS
    Masataka Oitate, Takashi Hirota, Kumiko Koyama, Shin-ichi Inoue, Kenji Kawai and Toshihiko Ikeda
    Drug Metabolism and Disposition August 2006, 34 (8) 1417-1422; DOI: https://doi.org/10.1124/dmd.106.009860
  • You have access
    PREDOMINANT CONTRIBUTION OF ORGANIC ANION TRANSPORTING POLYPEPTIDE OATP-B (OATP2B1) TO APICAL UPTAKE OF ESTRONE-3-SULFATE BY HUMAN INTESTINAL CACO-2 CELLS
    Yoshimichi Sai, Yosuke Kaneko, Satsuki Ito, Keisuke Mitsuoka, Yukio Kato, Ikumi Tamai, Per Artursson and Akira Tsuji
    Drug Metabolism and Disposition August 2006, 34 (8) 1423-1431; DOI: https://doi.org/10.1124/dmd.106.009530
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 34 (8)
Drug Metabolism and Disposition
Vol. 34, Issue 8
1 Aug 2006
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Short Communications
  • Articles
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics